Frag' FlorenceEvidenz. Klar. Anwendbar.
Uhr 7/8Sources Journal Tree
Easy Demo

Florence Themenbrowser · Onkologie · Seite 115

Was ist neu im Gesundheitswesen?

Entdecken Sie tatsächlich neu veröffentlichte Arbeiten aus Medizin, Pflege, Therapie, Public Health und Life Sciences. Sortiert nach Publikationsdatum, nicht nach Zitierhäufigkeit.

Themen erkunden

Aktuelle Forschung nach Fachgebiet

24 neue Nachweise auf dieser Seite Publiziert in den letzten 30 Tagen Neueste zuerst Crossref DOI
23.08.2026journal-article

Biomedicines

Integrated Molecular Profiling of Endometrial Cancer: NGS Findings, MSI/MMR Status, Histopathological Features, and TCGA-Inspired Molecular Classification

Merve Cirak-Balta, Suleyman Erdogdu, Busra Ekinci, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Ibrahim Halil Erdogdu, Nil Culhaci

Background/Objectives: Endometrial cancer is a heterogeneous malignancy that displays distinct molecular features and clinical behaviors. The molecular profile of endometrial cancer and its relationship with menopausal status, histological subtype, tumor grade, mismatch repair (MMR)/microsatellite instability (MSI) status, co-mutation patterns, and TCGA molecular classification were investigated in the current study. Methods: A total of 81 histopathologically confirmed endometrial cancer cases were retrospectively …

23.08.2026journal-article

Journal of Clinical Medicine

Safety and Efficacy of Brolucizumab in the Treatment of Patients with Diabetic Macular Edema and Diabetic Retinopathy: A Systematic Review and Meta-Analysis

Sharifa N. Bourisly, Fatmah S. Semairan, Yousef Mesaed Al-Shammari, Noor Alali, Lulwa Abbas Alfoudari, Abdulaziz F. Abdulkareem, Abdullah M. Alharran

Background: Brolucizumab is an intravitreal anti-vascular endothelial growth factor (anti-VEGF) agent developed to improve retinal drying and treatment durability in diabetic eye disease. However, its overall efficacy and safety in diabetic macular edema (DME) and diabetic retinopathy remain uncertain because available trials differ in population, comparator, dosing schedule, and follow-up. Methods: We searched PubMed, Cochrane Library, Scopus, and Web of Science from inception to 25 April 2026. Randomized controll …

23.08.2026journal-article

Journal of Child and Adolescent Psychopharmacology

Families’ Neighborhood Resources Predict Treatment Response for Regulating Together, a Group Therapy for Emotion Dysregulation in Autistic Youth

Walker S. McKinney, Lauren M. Schmitt, Jennifer R. Ruberg, Marika Coffman, Debra Reisinger, Rebecca C. Shaffer

Introduction: Autistic youth often face difficulties with emotion dysregulation (ED) and associated challenging behaviors. The Regulating Together (RT) group therapy was developed to treat ED in autistic youth ages 8–18 years and has been shown to be feasible, acceptable, and efficacious at reducing ED. Results from other clinical trials suggest the efficacy of behavioral therapies may vary based on family- or neighborhood-level social determinants of health (SDOH: “the conditions in the environments where people a …

23.08.2026journal-article

Cancers

Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib

Ahmet Kürşad Dişli, Ayşe Nuransoy Cengiz, Muhammet Cengiz, İrfan Buğday, Sinan Yıldırım, Rıdvan Gönül, Oktay Bozkurt, Mevlüde İnanç, Metin Özkan

Background/Objectives: Sunitinib and pazopanib are administered at fixed doses in patients with metastatic renal cell carcinoma (mRCC), without adjustment for body composition. This study aimed to investigate the association between body mass index (BMI) and treatment-related toxicity and treatment discontinuation in patients with mRCC receiving first-line sunitinib or pazopanib. Methods: A total of 136 patients with mRCC treated with sunitinib (n = 90) or pazopanib (n = 46) were retrospectively evaluated. BMI was …

23.08.2026journal-article

International Journal of Molecular Sciences

Blood Plasma Analysis in Ovarian Cancer Patients Using an AFM/MS Approach: Effect of Sample Dilution on Proteome Depth

Arina I. Gordeeva, Anastasia A. Konstantinova, Tatiana A. Materova, Elizaveta E. Rybakova, Maria O. Ershova, Nikita E. Vavilov, Victor G. Zgoda, Tatyana O. Pleshakova, Alexander I. Archakov

Early detection of ovarian cancer remains challenging because of the lack of sensitive and reproducible blood-based biomarkers. A major challenge in plasma proteomics is the extremely wide dynamic range of protein concentrations, which prevents simultaneous detection of both high- and low abundance proteins and limits the identification of disease-associated signals. In this study, we applied a combined atomic force microscopy and mass spectrometry (AFM/MS) approach to investigate how sample dilution affects plasma …

23.08.2026journal-article

Cancers

EIF3H Modulates Glycolysis Through LDHA Stabilization in Triple-Negative Breast Cancer

Xuyu Cheng, Xinghai Liu, Ziyu Feng, Xiaoan Liu

Background: Triple-negative breast cancer (TNBC) lacks effective targeted therapies, and its dependence on glycolysis represents a potential metabolic vulnerability. EIF3H, the largest subunit of the eukaryotic translation initiation factor 3 complex and a putative deubiquitinase, has been implicated in tumor progression, but its role in TNBC metabolism remains unclear. Methods: EIF3H expression and prognostic value were evaluated in public datasets, clinical TNBC specimens, and cell lines. Functional roles were ex …

23.08.2026journal-article

Diagnostics

Diagnostic Performance of Post-Treatment F-18 FDG PET/CT for Detecting Recurrent Cervical Cancer

Choon-Young Kim, Sang-Woo Lee, Gun Oh Chong, Jong Mi Kim, Yoon Hee Lee, Chae Moon Hong, Shin Young Jeong

Background/Objectives: Cervical cancer recurrence after definitive treatment remains a major clinical challenge, and early detection may improve patient outcomes. This study evaluated the diagnostic performance of fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) for detecting recurrent cervical cancer according to clinical context. Methods: We retrospectively reviewed 1727 post-treatment PET/CT examinations obtained from 659 patients who achieved a complete respons …

23.08.2026journal-article

Histopathology

AI for tumour proportion scoring of programmed death‐ligand 1 immunohistochemistry in non‐small cell lung cancer: a review of commercial and non‐commercial tools

Joachim Webers, Sandrina Martens, Pascal Gervois, Inge Mertens, Yuri Tolkach, Yves Sucaet, Esther Wolfs, Dirk Valkenborg

Programmed death‐ligand 1 (PD‐L1) expression, commonly quantified as tumour proportion score (TPS), is a key biomarker guiding immunotherapy in non‐small cell lung cancer (NSCLC). Manual scoring of PD‐L1 immunohistochemistry (IHC) is time‐consuming and challenged by preanalytical variability and interpretive subjectivity, which can hinder consistent treatment selection. Artificial intelligence (AI) tools aim to support more standardized PD‐L1 scoring. We compare publicly available evidence on PD‐L1 AI tools and ide …

23.08.2026journal-article

Smart Molecules

A photoimmune synergizing RNA interference technology for highly effective antitumor treatment

Xiang Xia, Bingbing Wu, Xueze Zhao, Wen Sun, Jianjun Du, Jiangli Fan, Xiaojun Peng

Abstract Photoimmunotherapy and RNA interference (RNAi) hold great potential for tumor therapy but exhibit limited efficacy as monotherapies. In this work, we report a red‐light‐activated combinatorial therapy that integrates photodynamic immunotherapy (PIT) with RNAi via a rationally designed photosensitizer, FNBS, developed on the basis of our previously reported advanced photosensitizer platform, HNBS. Upon cellular uptake and following red light irradiation, FNBS induces pyroptosis through the activation of nuc …

23.08.2026journal-article

Diabetes, Obesity and Metabolism

Variation in Treatment Patterns of Type 2 Diabetes in Older Patients

Phuc Le, Ning Guo, Anita Misra‐Hebert, Christopher B. Boyer, Kevin M. Pantalone, Hamlet Gasoyan, Nicholas J. Casacchia, Michael B. Rothberg

ABSTRACT Aims To estimate the proportion of older patients with type 2 diabetes (T2D) and HbA1c above or below goal at provider level and explore factors associated with patients being above or below goal. Materials and Methods We used 2023 Cleveland Clinic electronic health records, including patients ≥ 65 years old with T2D, ≥ 1 diabetes medication and ≥ 1 HbA1c measurement. Patients were assigned to their listed primary care provider or the one they saw most frequently and stratified into good, intermediate, or …

23.08.2026journal-article

Public Health Reports®

Cardiovascular-Related Death Among Women With Breast Cancer in the United States: Do We Need a Better Approach for Estimating Rates?

Nguyen Le, Yan Liu, Chanhyun Park

Breast cancer is the most common cancer among women in the United States, and cardiovascular disease (CVD) is a leading cause of death in this population. Understanding CVD-related death among breast cancer survivors is critical to inform policies. Previous studies calculating CVD-related death rates in this population used data from the Centers for Disease Control and Prevention (CDC) Wide-ranging ONline Data for Epidemiologic Research (WONDER) with the general US female population as the denominator, which may ha …

23.08.2026journal-article

Arthroscopy Techniques

Fixation Treatment of Anterior Cruciate Ligament Avulsion Fracture via Suture‐Bridge Technique Through Transtibial Tunnels

Peisi Hou, Chenyang Meng, Jie Xu, WenQiang Zhao, Yuhang Wei, Changxu Han

Abstract Surgical intervention is usually required for type III/IV avulsion fractures of the inferior insertion of the anterior cruciate ligament. Arthroscopically assisted suture‐bridge technique with anchors and trans‐tibial tunnel pull‐out suture fixation using high‐strength sutures are currently common surgical methods. However, the biomechanical performance of anchor fixation and transosseous tunnel pull‐out fixation is suboptimal. For patients with high sports demands or those who need to return to competitiv …

23.08.2026journal-article

Molecules

Improved Lipophilicity Is Associated with the Cytotoxic Activity of Chlorogenic Acid Esters in In Vitro Colorectal Cancer Models

Ana María Castañeda-Cifuentes, Johanna Pedroza-Díaz, Gloria A. Santa-González, Isabel Cristina Henao-Castañeda, Andrea Johanna Andrea Báez, Jorge L. Jios, Ana Laura Di Virgilio

Chlorogenic acid (CGA) exhibits anticancer activity in colorectal cancer (CRC), but its clinical application is limited by low lipophilicity. To improve its physicochemical properties, four CGA esters (methyl, ethyl, n-propyl, and n-butyl chlorogenates) were synthesized and evaluated. Physicochemical properties were characterized in silico, and their biological activity was assessed in SW480, HT-29, and non-tumoral NCM460 cell lines using viability assays and flow cytometry. Molecular docking studies were performed …

22.08.2026journal-article

Cancer Causes & Control

“I never thought to bring them up to the doctor”: examining symptom appraisal, help-seeking behaviors, and diagnostic delays among young adults with cancer

Natasha C. Allard, Elizabeth G. Bouchard, Jennifer S. Ford, Thomas Hugh Feeley, Denise Rokitka, Heather Orom

Abstract Purpose Cancer incidence is rising among young adults (20–39 years), and it is one of the top five causes of death for this age group. Young adults often experience longer delays in diagnosis than children and older adults, which negatively impacts survival and quality of life. Communication interventions might help reduce these delays, but understanding the factors driving delays is crucial for developing effective strategies. Methods We conducted semi-structured interviews with 30 young adults diagnosed …

22.08.2026journal-article

Diseases of the Esophagus

P1.202. Management and Outcomes of Anastomotic Leak After Oesophagectomy in Patients With Oesophageal Cancer

Apurva Ashok, Soumyabrata Ghosh, Tarun Joseph, Gangireddy Sivasankar Reddy, Moses Arunsingh, Robin Thambudorai

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – early outcomes and complications Background Anastomotic leak (AL) after oesophagectomy is a dreaded complication with significant implications on patient outcomes. Early detection of leak, advances in perioperative care and management techniques may improve long-term outcomes. This study was performed to assess the management patterns of anastomotic leak and its short-term and long-term consequences. Methods A retrospective study was conduc …

22.08.2026journal-article

Diseases of the Esophagus

P1.239. Clinical Outcomes of Conversion Surgery for Locally Advanced Esophageal Cancer With Mediastinal M1b Lymph Node Metastasis

Tetsuya Abe, Takahiro Hosoi, Kosuke Inada, Kotaro Ozaki, Eiji Higaki

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – long term outcomes Background The role of conversion surgery (CS) for locally advanced esophageal cancer with mediastinal M1b lymph node metastasis has not yet been clearly defined. Methods We evaluated the therapeutic outcomes of 27 patients who underwent conversion surgery (CS) for locally advanced esophageal cancer with mediastinal M1b lymph node metastasis, among 1,030 patients who underwent thoracic esophagectomy at our institution bet …

22.08.2026journal-article

Pain Medicine

Celiac Plexus Block with versus without Botulinum Toxin Type A for Pancreatic Cancer Pain: A Retrospective Comparative Study

Kaehong Lee, Seungpyo Nam, Seungcheol Yu, Jeongsoo Kim

Abstract Objective To evaluate whether the addition of botulinum toxin type A (BTX) to celiac plexus block (CPB) is associated with improved analgesic outcomes in patients with pancreatic cancer pain. Design Retrospective observational study. Setting Single-center tertiary hospital. Subjects A total of 60 patients with pancreatic cancer pain who underwent fluoroscopy-guided CPB between January 2022 and November 2025. Methods Patients were divided into CPB only (n = 34) and CPB with BTX (n = 26) groups. Pain intensi …

22.08.2026journal-article

Cell Biochemistry and Biophysics

Host-Derived Proteomic Profiling of Human and Canine Mammary Tumor Xenografts Identifies Enrichment of Lipid Metabolism-Related Pathways

Elisa Díaz-Grijuela, Saioa Goñi, Alejandro Urdiciain, Miguel Barajas, Ileana B. Gonzalez-Valdes, Maider Espinal, Claudia Caballero-Mínguez, Enrique Santamaria, Agustín Hernández, Egoitz Astigarraga, Gabriel Barreda-Gómez, Raquel Urtasun, Joaquín Fernandez-Irigoyen

Abstract Breast cancer is the most frequently diagnosed cancer in women worldwide and one of the most common malignancies in dogs. Notable clinical, hormonal and molecular similarities between both species suggest that dogs may serve as a valuable comparative oncology model. Alterations in lipid homeostasis and metabolism are closely associated with the acquisition of cancer hallmarks. In this study, a comparative proteomic analysis of murine host-derived proteins was performed in cell line-derived xenograft (CDX) …

22.08.2026journal-article

Diseases of the Esophagus

P1.090. Innovative Push Percutaneous Endoscopic Gastrostomy Using Thread-Through-Trap and Alken Dilator in Advanced Esophageal and Head and Neck Cancer

Prasit Mahawongkajit, Worapong Anuponganan

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – technique Background Percutaneous endoscopic gastrostomy (PEG) using the push technique is a minimally invasive alternative to surgical gastrostomy that reduces procedure-related morbidity and the risk of tumor seeding. This approach is particularly beneficial in patients with advanced esophageal and head and neck cancers. Methods An innovative push-PEG technique, termed Thread The Thread Though Trap and Alken Metal Dilator (5TAMeD) techniq …

22.08.2026journal-article

Diseases of the Esophagus

P1.086. Impact of Surgery Versus Non-Surgery on the Prognosis of Esophageal Cancer Patients With Clinically Identified Metastatic Supraclavicular Lymph Nodes

Yiheng Huang, Yuqin Cao, Hecheng Li

Abstract Topic Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies Background The clinical significance of supraclavicular lymph node (SCLN) involvement in esophageal cancer remains controversial. The role of surgery in managing patients with SCLN metastases remains uncertain. This study evaluates the prognostic outcomes of patients with SCLN-positive esophageal cancer who received either surgical or nonsurgical treatment, aiming to develop evidence-based management strategies for this subgroup. Methods A retros …

22.08.2026journal-article

Diseases of the Esophagus

OA08.5. Incidence of Lymph Node Metastases in pT1 Chemo- and Radiotherapy Naïve Esophageal and Gastric Cancer in the Nordic Countries

David Edholm, Joonas H Kauppila, Michael P Achiam, Oliver Nørholm Kempf, Tobias Hauge, Mats Lindblad, Tom Mala

Abstract Topic Esophageal Cancer: Barrett‘s Esophagus: High-Grade Dysplasia and Early Invasive Cancer Background Although endoscopic resection is reported to be safe for early stage esophagogastric cancer, uncertainty remains regarding oncological efficacy, particularly for submucosal lesions. The aim of this study was to assess the frequency of lymph node metastasis (LNM) and survival in patients operated for chemo- and radiotherapy naïve pT1 esophagogastric cancer. Methods Patients who underwent surgical resectio …

22.08.2026journal-article

Current Oncology Reports

Percutaneous Management of Desmoid Tumors

Gina P. Landinez, Shakthi Kumaran Ramasamy, Xiao Wu, Kiyon Naser-Tavakolian, Abin Sajan, Areeb Siddiqui, John Moody, Kirema Garcia-Reyes, Junaid Raja, Venkatesh P. Krishnasamy

Abstract Purpose of Review To provide a comprehensive review of percutaneous image-guided techniques in the management of desmoid tumors including evolving thermal and non-thermal ablation options, as well as trans-arterial catheter options. Beyond each treatment modality, we aim to highlight considerations related to patient selection, technical components, and the growing interplay between percutaneous therapies and emerging systemic therapies. Recent Findings Percutaneous ablation, particularly cryoablation, has …

22.08.2026journal-article

Effective Pharmacotherapy

Justification for the Redundancy of Wide Axillary Llymphodissection in Patients with Early Breast Cancer who Developed Ttransformation from Iinitial cN1 to Complete Clinical Response after Neoadjuvant Chemotherapy

S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, D.A. Karseladze, K.S. Titov, I.N. Lebedinsky, I.N. Kutz, D.D. Dolidze, S.S. Lebedev, A.A. Tatarova, E.Yu. Neretin, RUDN University, Moscow, Russian Medical Academy of Continuous Professional Education, Moscow

The aim of the study was to determine the feasibility of de-escalation of the volume of lymphodissection by performing selective target biopsy of the sentinel lymph node in patients with initial stage cN1 disease who progressed to cN0 after NACT and demonstrate that this approach does not result in worsening oncological outcomes or local recurrences. For this purpose, 345 patients with primary operable breast cancer were studied. In the first stage, the patients received NACT followed by radical surgery in the peri …

22.08.2026journal-article

Diseases of the Esophagus

PD06.09. Second-Line Treatment Efficacy in Functional Heartburn Based on HRM and MII-pH Evaluation

Hiromi Arakawa, Tomoaki Matsumura, Tomomi Ozaki, Miyuki Iwasaki, Michiko Sonoda, Jun Kato

Abstract Topic Benign Disease: Gastro-Esophageal Reflux and Hiatal Hernia Background Functional heartburn (FH) accounts for approximately half of patients with proton pump inhibitor (PPI)- or vonoprazan-refractory non-erosive reflux symptoms. However, the clinical characteristics of FH and the efficacy of second-line therapies remain incompletely understood. We evaluated patient characteristics and treatment outcomes following physiological evaluation. Methods Between September 2013 and December 2025, we retrospect …